Our results suggested that suppressing TRAF4, TRAF5, or TRAF6 can decrease the proliferation of ovarian cancer and melanoma cells and improve the sensitivity of these cells to retinoic acid treatment, probably by regulating cell apoptosis-related signaling pathways. The gene discussed is TRAF6; the disease is ovarian carcinoma.